Addison Disease
13
1
1
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
1 terminated out of 13 trials
85.7%
-0.8% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Telehealth Music Therapy for Adults With Endocrine Disorder and Depression
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
A Study of Markers of Glucocorticoid Effects in Patients With Addisons Disease (DOSCORT)
Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia
Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes
Does Relative Hypoglycaemia &/or Sleep Disturbance Contribute to the Lethargy Observed in Addison's Disease
Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders
Biomarker(s) for Glucocorticoids
Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Adrenal Function After Living Kidney Donation
Effect of Cortisol on Physical Exertion in Patients With Primary Adrenal Failure
Effects and Interactions of Liquorice and Grapefruit on Glucocorticoid Replacement Therapy in Addison's Disease